Mendelian randomisation study of smoking exposure in relation to breast cancer risk

被引:14
|
作者
Park, Hanla A. [1 ,2 ]
Neumeyer, Sonja [1 ]
Michailidou, Kyriaki [3 ,4 ,5 ]
Bolla, Manjeet K. [5 ]
Wang, Qin [5 ]
Dennis, Joe [5 ]
Ahearn, Thomas U. [6 ]
Andrulis, Irene L. [7 ,8 ]
Anton-Culver, Hoda [9 ]
Antonenkova, Natalia N. [10 ]
Arndt, Volker [11 ]
Aronson, Kristan J. [12 ]
Augustinsson, Annelie [13 ]
Baten, Adinda [14 ]
Freeman, Laura E. Beane [6 ]
Becher, Heiko [15 ,16 ]
Beckmann, Matthias W. [17 ]
Behrens, Sabine [1 ]
Benitez, Javier [18 ,19 ]
Bermisheva, Marina [20 ]
Bogdanova, Natalia, V [10 ,21 ,22 ]
Bojesen, Stig E. [23 ,24 ,25 ]
Brauch, Hiltrud [26 ,27 ,28 ]
Brenner, Hermann [11 ,29 ,30 ,31 ]
Brucker, Sara Y. [32 ]
Burwinkel, Barbara [33 ,34 ]
Campa, Daniele [1 ,35 ]
Canzian, Federico [36 ]
Castelao, Jose E. [37 ]
Chanock, Stephen J. [6 ]
Chenevix-Trench, Georgia [38 ]
Clarke, Christine L. [39 ]
Conroy, Don M. [40 ]
Couch, Fergus J. [41 ]
Cox, Angela [42 ]
Cross, Simon S. [42 ,43 ]
Czene, Kamila [44 ]
Daly, Mary B. [45 ]
Devilee, Peter [46 ,47 ]
Dork, Thilo [22 ]
Dos-Santos-Silva, Isabel [48 ]
Dwek, Miriam [49 ]
Eccles, Diana M. [50 ]
Eliassen, A. Heather [51 ,52 ,53 ]
Engel, Christoph [54 ]
Eriksson, Mikael [44 ]
Evans, D. Gareth [55 ,56 ]
Fasching, Peter A. [17 ,57 ]
Flyger, Henrik [58 ]
Fritschi, Lin [59 ]
机构
[1] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[2] Heidelberg Univ, Fac Med, Heidelberg, Germany
[3] Cyprus Inst Neurol & Genet, Biostat Unit, Nicosia, Cyprus
[4] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus
[5] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England
[6] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA
[7] Mt Sinai Hosp, Fred A Litwin Ctr Canc Genet, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[8] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[9] Univ Calif Irvine, Genet Epidemiol Res Inst, Dept Epidemiol, Irvine, CA USA
[10] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS
[11] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[12] Queens Univ, Canc Res Inst, Dept Publ Hlth Sci, Kingston, ON, Canada
[13] Lund Univ, Dept Canc Epidemiol, Clin Sci, Lund, Sweden
[14] Univ Hosp Leuven, Leuven Multidisciplinary Breast Ctr, Leuven Canc Inst, Dept Oncol, Leuven, Belgium
[15] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany
[16] Charite Univ Med Berlin, Inst Biometry & Clin Epidemiol, Berlin, Germany
[17] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Comprehens Canc Ctr ER EMN, Dept Gynecol & Obstet, Erlangen, Germany
[18] Ctr Invest Red Enfermedades Raras CIBERER, Madrid, Spain
[19] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Programme, Madrid, Spain
[20] Russian Acad Sci, Inst Biochem & Genet, Ufa Fed Res Ctr, Ufa, Russia
[21] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany
[22] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany
[23] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev, Denmark
[24] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark
[25] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[26] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[27] Univ Tubingen, iFIT Cluster Excellence, Tubingen, Germany
[28] German Canc Res Ctr, German Canc Consortium DKTK, Partner Site Tubingen, Tubingen, Germany
[29] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany
[30] Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[31] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
[32] Univ Tubingen, Dept Gynecol & Obstet, Tubingen, Germany
[33] German Canc Res Ctr, Mol Epidemiol Grp, C080, Heidelberg, Germany
[34] Heidelberg Univ, Univ Womens Clin Heidelberg, Mol Biol Breast Canc, Heidelberg, Germany
[35] Univ Pisa, Dept Biol, Pisa, Italy
[36] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany
[37] Xerencia Xest Integrada Vigo SERGAS, Oncol & Genet Unit, Inst Invest Sanitaria Galicia Sur IISGS, Vigo, Spain
[38] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia
[39] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia
[40] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England
[41] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[42] Univ Sheffield, Sheffield Inst Nucl Acids SInFoNiA, Dept Oncol & Metab, Sheffield, S Yorkshire, England
[43] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Sheffield, S Yorkshire, England
[44] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[45] Fox Chase Canc Ctr, Dept Clin Genet, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[46] Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands
[47] Leiden Univ Med Ctr, Dept Human Genet, Leiden, Netherlands
[48] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England
[49] Univ Westminster, Sch Life Sci, London, England
[50] Univ Southampton, Fac Med, Southampton, Hants, England
基金
英国医学研究理事会; 加拿大健康研究院; 美国国家卫生研究院; 瑞典研究理事会; 芬兰科学院; 英国惠康基金; 俄罗斯基础研究基金会;
关键词
CIGARETTE-SMOKING; WOMEN; ALCOHOL; ASSOCIATION; INFERENCE; TOBACCO; TISSUE;
D O I
10.1038/s41416-021-01432-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Despite a modest association between tobacco smoking and breast cancer risk reported by recent epidemiological studies, it is still equivocal whether smoking is causally related to breast cancer risk. Methods We applied Mendelian randomisation (MR) to evaluate a potential causal effect of cigarette smoking on breast cancer risk. Both individual-level data as well as summary statistics for 164 single-nucleotide polymorphisms (SNPs) reported in genome-wide association studies of lifetime smoking index (LSI) or cigarette per day (CPD) were used to obtain MR effect estimates. Data from 108,420 invasive breast cancer cases and 87,681 controls were used for the LSI analysis and for the CPD analysis conducted among ever-smokers from 26,147 cancer cases and 26,072 controls. Sensitivity analyses were conducted to address pleiotropy. Results Genetically predicted LSI was associated with increased breast cancer risk (OR 1.18 per SD, 95% CI: 1.07-1.30, P = 0.11 x 10(-2)), but there was no evidence of association for genetically predicted CPD (OR 1.02, 95% CI: 0.78-1.19, P = 0.85). The sensitivity analyses yielded similar results and showed no strong evidence of pleiotropic effect. Conclusion Our MR study provides supportive evidence for a potential causal association with breast cancer risk for lifetime smoking exposure but not cigarettes per day among smokers.
引用
收藏
页码:1135 / 1145
页数:11
相关论文
共 50 条
  • [1] Mendelian randomisation study of smoking exposure in relation to breast cancer risk
    Hanla A. Park
    Sonja Neumeyer
    Kyriaki Michailidou
    Manjeet K. Bolla
    Qin Wang
    Joe Dennis
    Thomas U. Ahearn
    Irene L. Andrulis
    Hoda Anton-Culver
    Natalia N. Antonenkova
    Volker Arndt
    Kristan J. Aronson
    Annelie Augustinsson
    Adinda Baten
    Laura E. Beane Freeman
    Heiko Becher
    Matthias W. Beckmann
    Sabine Behrens
    Javier Benitez
    Marina Bermisheva
    Natalia V. Bogdanova
    Stig E. Bojesen
    Hiltrud Brauch
    Hermann Brenner
    Sara Y. Brucker
    Barbara Burwinkel
    Daniele Campa
    Federico Canzian
    Jose E. Castelao
    Stephen J. Chanock
    Georgia Chenevix-Trench
    Christine L. Clarke
    Don M. Conroy
    Fergus J. Couch
    Angela Cox
    Simon S. Cross
    Kamila Czene
    Mary B. Daly
    Peter Devilee
    Thilo Dörk
    Isabel dos-Santos-Silva
    Miriam Dwek
    Diana M. Eccles
    A. Heather Eliassen
    Christoph Engel
    Mikael Eriksson
    D. Gareth Evans
    Peter A. Fasching
    Henrik Flyger
    Lin Fritschi
    British Journal of Cancer, 2021, 125 : 1135 - 1145
  • [2] Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
    Escala-Garcia, Maria
    Morra, Anna
    Canisius, Sander
    Chang-Claude, Jenny
    Kar, Siddhartha
    Zheng, Wei
    Bojesen, Stig E.
    Easton, Doug
    Pharoah, Paul D. P.
    Schmidt, Marjanka K.
    BMC MEDICINE, 2020, 18 (01)
  • [3] Personal history of irradiation and risk of breast cancer: A Mendelian randomisation study
    Liu, Yaoyao
    Liu, Zeyu
    Chen, Jiaru
    Liang, Manfeng
    Cai, Chunqing
    Zou, Fei
    Zhou, Xueqiong
    JOURNAL OF GLOBAL HEALTH, 2024, 14
  • [4] Breast cancer risk factors and their effects on survival: a Mendelian randomisation study
    Maria Escala-Garcia
    Anna Morra
    Sander Canisius
    Jenny Chang-Claude
    Siddhartha Kar
    Wei Zheng
    Stig E. Bojesen
    Doug Easton
    Paul D. P. Pharoah
    Marjanka K. Schmidt
    BMC Medicine, 18
  • [5] Smoking and the risk of glaucoma: a Mendelian randomisation study in UK Biobank
    Kennedy , Marianne Therese
    Kennedy, Oliver J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [6] Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
    Dixon-Suen, Suzanne C.
    Lewis, Sarah J.
    Martin, Richard M.
    English, Dallas R.
    Boyle, Terry
    Giles, Graham G.
    Michailidou, Kyriaki
    Bolla, Manjeet K.
    Wang, Qin
    Dennis, Joe
    Lush, Michael
    Ahearn, Thomas U.
    Ambrosone, Christine B.
    Andrulis, Irene L.
    Anton-Culver, Hoda
    Arndt, Volker
    Aronson, Kristan J.
    Augustinsson, Annelie
    Auvinen, Paivi
    Beane Freeman, Laura E.
    Becher, Heiko
    Beckmann, Matthias W.
    Behrens, Sabine
    Bermisheva, Marina
    Blomqvist, Carl
    Bogdanova, Natalia, V
    Bojesen, Stig E.
    Bonanni, Bernardo
    Brenner, Hermann
    Bruening, Thomas
    Buys, Saundra S.
    Camp, Nicola J.
    Campa, Daniele
    Canzian, Federico
    Castelao, Jose E.
    Cessna, Melissa H.
    Chang-Claude, Jenny
    Chanock, Stephen J.
    Clarke, Christine L.
    Conroy, Don M.
    Couch, Fergus J.
    Cox, Angela
    Cross, Simon S.
    Czene, Kamila
    Daly, Mary B.
    Devilee, Peter
    Doerk, Thilo
    Dwek, Miriam
    Eccles, Diana M.
    Eliassen, A. Heather
    BRITISH JOURNAL OF SPORTS MEDICINE, 2022, 56 (20) : 1157 - 1170
  • [7] Coffee consumption and cancer risk: a Mendelian randomisation study
    Carter, Paul
    Yuan, Shuai
    Kar, Siddhartha
    Vithayathil, Mathew
    Mason, Amy M.
    Burgess, Stephen
    Larsson, Susanna C.
    CLINICAL NUTRITION, 2022, 41 (10) : 2113 - 2123
  • [8] Fast walking reduces the risk of breast cancer: evidence from a Mendelian randomisation study
    Wang, He
    Wang, Yue
    Liu, Shuaian
    Song, Ziqi
    Liu, Shangjie
    Jia, Zhifeng
    INTERNATIONAL JOURNAL OF SPORT AND EXERCISE PSYCHOLOGY, 2025, 23 (01) : 26 - 39
  • [9] Cigarette smoking and schizophrenia: Mendelian randomisation study
    Chen, Jianhua
    Chen, Ruirui
    Xiang, Siying
    Li, Ningning
    Gao, Chengwen
    Wu, Chuanhong
    Zhang, Qian
    Zhao, Yalin
    Liao, Yanhui
    Stewart, Robert
    Xu, Yifeng
    Shi, Yongyong
    Li, Zhiqiang
    BRITISH JOURNAL OF PSYCHIATRY, 2021, 218 (02) : 98 - 103
  • [10] Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study
    Vermeulen, Jentien M.
    Wootton, Robyn E.
    Treur, Jorien L.
    Sallis, Hannah M.
    Jones, Hannah J.
    Zammit, Stanley
    van den Brink, Wim
    Goodwin, Guy M.
    de Haan, Lieuwe
    Munafo, Marcus R.
    BRITISH JOURNAL OF PSYCHIATRY, 2021, 218 (02) : 88 - 94